Klebsiella pneumoniae infection increases risk of Alzheimer's Disease in the UK Biobank cohort.
| Autor: | Lehrer S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York., Rheinstein PH; Severn Health Solutions, Severna Park, Maryland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | MedRxiv : the preprint server for health sciences [medRxiv] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22. |
| DOI: | 10.1101/2024.11.21.24317739 |
| Abstrakt: | Background: Infections, including bacterial pathogens, have been implicated in Alzheimer's disease (AD) risk. Klebsiella pneumoniae (K. pneumoniae) is a common hospital-acquired pathogen associated with significant inflammation, which may contribute to neurodegeneration. This study investigates the relationship between K. pneumoniae infections and AD in the UK Biobank cohort. Methods: Using UK Biobank data, we assessed AD diagnoses based on linked healthcare records and identified K. pneumoniae infections using ICD-10 codes B96.1 and J15.0. A cohort of 502,494 participants was analyzed for AD incidence in relation to demographic factors, educational years, APOE isoforms, and history of K. pneumoniae infection. Logistic regression was used to assess the association between K. pneumoniae infection and AD risk. Results: AD incidence was significantly higher among participants with a history of K. pneumoniae infection (1.0%) compared to those without (0.2%; p < 0.001, Fisher's exact test two tailed). Logistic regression analysis revealed that K. pneumoniae infection was associated with an increased risk of AD (OR = 3.32, p < 0.001), independent of age, sex, education, and APOE isoform. Additionally, AD risk was higher among ε4ε4 carriers and increased with age but decreased with additional years of education. Conclusion: Our findings suggest that K. pneumoniae infection may be an independent risk factor for AD. This association underscores the need for further research into infection control and its role in mitigating neurodegenerative disease risk, particularly in populations susceptible to healthcare-associated infections. Competing Interests: Conflicts of interest: The authors declare that they have no competing interests. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|